Study on Clinical Characteristics of Thyroid Nodules
1.Department of Geriatric Endocrinology,First Affiliated Hospital of Kunming Medical University,Kunming 650032,China
2.Second Department of Respiratory and Critical Care Medicine,First Affiliated Hospital of Kunming Medical University,Kunming 650032,China
3.Experimental Teaching Center,School of Basic Medical Sciences,Kunming Medical University,Kunming 650500,China
*Corresponding author:SHEN Yun,Professor;E-mail:1263416107@qq.com
[1]中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会,中华医学会核医学分会.甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志,2012,28(10):779-797.DOI:10.3760/cma.j.issn.10006699.2012.10.002.
Chinese Society of Endocrinology,Group of Endocrinology,Chinese Society of Surgery,Chinese Anti-cancer Association,Committee of Head and Neck Tumor,Chinese Anti-Cancer Association.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Chin J Endocrinol Metab,2012,28(10):779-797.DOI:10.3760/cma.j.issn.10006699.2012.10.002.
[2]中国肥胖问题工作组.中国成人超重和肥胖症预防与控制指南(节录)[J].营养学报,2004,26:1-4.DOI:10.3321/j.issn.0512-7955.2004.01.001.
Working Group on Obesity in China.Guidelines for prevention and control of overweight and obesity in Chinese adults(excerpts)[J].Journal of Nutrition,2004,26:1-4.DOI:10.3321/j.issn.0512-7955.2004.01.001.
[3]中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版 )[J].中国循环杂志,2016,31(10):937-950.DOI:10.3969/j.issn.1000-3614.2016.10.001.
[4]DAL MASO L,LISE M,ZAMBON P,et al.Incidence of thyroid cancer in Italy,1991—2005:time trends and age period-cohort effects[J].Ann Oncol,2011,22(4):957-963.DOI:10.1093/annonc/mdq467.
[5]SUNDRAM F,ROBINSON B G,KUNG A,et al.Well-differentiated epithelial thyroid cancer management in the Asia Pacific region:a report and clinical practice guideline[J].Thyroid,2006,16(5):461-469.DOI:10.1089/thy.2006.16.461.
[6]吴娟,冯红芳,李祥,等.1358例甲状腺结节的临床与病理特征分析[J].临床外科杂志,2016,24(3):197-200.DOI:10.3969/j.issn.1005-6483.2016.03.012.
WU J,FENG H F,LI X,et al.Clinical and pathological analysis of 1358 patients with thyroid nodles[J].J Clin Surg,2016,24(3):197-200.DOI:10.3969/j.issn.1005-6483.2016.03.012.
[7]BOELAERT K,HORAEEK J,HOLDER R L,et al.Serum thyrotropine concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration[J].Clin Endocrinol Metab,2006,91(11):4295-4301.DOI:10.1210/jc.2006-0527.
[8]KITAHARA C M,PLATZ E A,FREEMAN L E,et al.Obesity and thyroid cancer risk among U.S. men and women:a pooled analysis of five prospective studies[J].Cancer Epidemiol Biomarkers Prev,2011,20(3):464-472.DOI:10.1158/1055-9965.EPI-10-1220.
[9]汪自清,齐元富.炎症:肿瘤的催化剂[J].世界最新医学信息文摘,2016,16(14):70-71.DOI:10.3969/j.issn.1671-3141.2016.14.027.
WANG Z Q,QI Y F.Inflammation:a catalyst for cancer[J].World Latest Medicine Information,2016,16(14):70-71.DOI:10.3969/j.issn.1671-3141.2016.14.027.
[10]CHEN S T,HSUEH C,CHIOU W K,et al.Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus[J].PLoS One,2013,8(1):e55179.DOI:10.1371/journal.pone.0055179.
[11]BORENA W,STOCKS T,JONSSON H,et al.Serum triglycerides and cancer risk in the metabolic syndrome and cancer(Me-can) collaborative study[J].Cancer Causes Control,2011,22(2):291-299.DOI:10.1007/s10552-010-9697-0.
[12]LI L C,JAYARAMA S,PILLI T,et al.Down-modulation of expression,or dephosphorylation,of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand[J].Thyroid,2013,23(1):70-78.DOI:10.1089/thy.2012.0155.
[13]董芬,张彪,单广良.中国甲状腺癌的流行现状和影响因素[J].中国癌症杂志,2016,26(1):47-52.DOI:10.3969/j.issn.1007-3969.2016.01.008.
DONG F,ZHANG B,SHAN G L.Distribution and risk factors of thyroid cancer in China[J].China Oncology,2016,26(1):47-52.DOI:10.3969/j.issn.1007-3969.2016.01.008.
[14]KIM E K,PARK C S,CHUNG W Y,et al.New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid[J].AJR Am J Roentgenol,2002,178(3):687-691.DOI:10.2214/ajr.178.3.1780687.
[15]PAPINI E,GUGLIEIMI R,BIANCHINI A,et al.Risk of malignaney in nonpalpable thyroid nodules:predictive value of ultrasound and color-Doppler features[J].J Clin Endocrinol Mctab,2002,87(5):1941-1946.DOI:10.1210/jcem.87.5.8504.
[16]MOON W J,JUNG S L,LEE J H,et al.Benign and malignant thyroid nodules:US differentiation-multicenter retrospective study[J].Radiology,2008,247(3):762-770.DOI:10.1148/radiol.2473070944.
[17]SEIBERLING K A,DUTRA J C,GRANT T,et al.Role of intrathyroidal calcifications detected on ultrasound as a marker of malignancy[J].Laryngoscope,2004,114(10):1753-1757.DOI:10.1097/00005537-200410000-00014.
[18]ZHANG T,LI F X,MU J L,et al.Multivariate evaluation of Thyroid Imaging Reporting and Data System(TI-RADS) in diagnosis malignant thyroid nodule:application to PCA and PLS-DA analysis[J].Int J Clin Oncol,2017,22(3):448-454.DOI:10.1007/s10147-017-1098-x.
[19]LIU M J,LIU Z F,HOU Y Y,et al.Ultrasonographic characteristics of medullary thyroid carcinoma:a comparison with papillary thyroid carcinoma[J].Oncotarget,2017,8(16):27520-27528.DOI:10.18632/oncotarget.15897.